Furthermore, blocking the activation of STAT3 by Stattic, a STAT3 inhibitor, could inhibit the viability of ESCC cells and down-regulate the expression of VEGF and Cyclin D1. The gene discussed is VEGFA; the disease is esophageal squamous cell carcinoma.